Minghui Li

Minghui Li

Auto-generated profile, based on publicly available information

Minghui Li

GRU Cancer Center, Georgia Regents University, Augusta, Georgia, 30912, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
MLMinghui Li
Minghui Li
ABAaron R Bolduc
Aaron R Bolduc
NHNasrul Hoda
Nasrul Hoda
DGDenise N Gamble
Denise N Gamble
SDSarah-Bianca Dolisca
Sarah-Bianca Dolisca
TJTheodore S Johnson
Theodore S Johnson
Indoleamine 2,3-dioxygenase (IDO) is an enzyme with immune-suppressive properties that is commonly exploited by tumors to evade immune destruction. Anti-tumor T cell responses can be initiated in solid tumors, but are immediately suppressed by compensatory upregulation of immunological checkpoints, including IDO. In addition to these known effects on the adaptive immune system, we previously showed widespread, T cell-dependent complement deposition during allogeneic fetal rejection upon maternal treatment with IDO-blockade. We hypothesized that IDO protects glioblastoma from the full effects of chemo-radiation therapy by preventing vascular activation and complement-dependent tumor destruction.